LPL Financial »

Cadrenal Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $196k 14k 13.83

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Cadrenal Therapeutics

Vanguard Group
Citadel Advisors
LPL Financial
Geode Capital Management
Jpmorgan Chase & Co
BlackRock
Advisor Group Holdings
Morgan Stanley
Rockefeller Capital Management
Jones Financial Companies, L.L
Hartland & Co
Harbour Investments
Wells Fargo & Company
UBS Group
Archer Investment Corp

View all funds holding Cadrenal Therapeutics